Risk of Community-Acquired Pneumococcal Bacteremia in Patients With Diabetes
- 1 May 2004
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (5) , 1143-1147
- https://doi.org/10.2337/diacare.27.5.1143
Abstract
OBJECTIVE—We conducted this population-based case-control study to examine whether diabetes is associated with an increased risk of community-acquired pneumococcal bacteremia. RESEARCH DESIGN AND METHODS—We included 598 cases in the North Jutland County Bacteremia Registry, Denmark, with residence in the county and a first hospitalization for community-acquired pneumococcal bacteremia from 1992 through 2001. Ten sex- and age-matched population control subjects per case were selected, using a unique personal identifier. Diabetes was determined by record linkage with the County Prescription Database (for prescriptions for antidiabetic drugs) and the Hospital Discharge Registry (for previous hospitalizations with diabetes or diabetic complications). We performed conditional logistic regression to estimate odds ratios (ORs) for pneumococcal bacteremia among diabetic and nondiabetic persons, with adjustment for a range of comorbid diseases considered to be risk factors for pneumococcal infection. RESULTS—The crude OR for pneumococcal bacteremia in persons with diabetes was 1.9 (95% CI 1.4–2.6). After adjustment for comorbidity, the OR decreased to 1.5 (95% CI 1.1–2.0). The impact of diabetes on the risk for pneumococcal bacteremia was most pronounced in adults aged 40 years and younger (adjusted OR 4.2, 95% CI 1.1–16.7) and in persons without any other coexisting morbidity (adjusted OR 2.3, 95% CI 1.3–3.9). Under the assumptions that the association was causal and that there is a 5% overall prevalence of diabetes in our study population, 24 of 1,000 admissions with incident pneumococcal bacteremia may be attributed to diabetes. CONCLUSIONS—Diabetes seems to be a risk factor for community-acquired pneumococcal bacteremia.Keywords
This publication has 20 references indexed in Scilit:
- Vaccines for preventing pneumococcal infection in adultsPublished by Wiley ,2003
- An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical OutcomeClinical Infectious Diseases, 2003
- Immunization and the prevention of influenza and pneumococcal disease in people with diabetes: American Diabetes Association.Diabetes Care, 2000
- Pneumococcal Bacteremia in Adults: A 14-Year Experience in an Inner-City University HospitalClinical Infectious Diseases, 1995
- The impact of the first notification of positive blood cultures on antibiotic therapyAPMIS, 1995
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Pneumococcal bacteraemia during a recent decadeJournal of Infection, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Bacteremia in Diabetic Patients: Comparison of Incidence and Mortality with Nondiabetic PatientsDiabetes Care, 1985
- Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital.BMJ, 1985